Gynecor, a subspecialty division of Bostwick Laboratories, is focused exclusively on gynecologic pathology. For over ten years, our dedicated and skilled board-certified pathologists have been committed to providing the highest quality of pathology services to our clients and the patients they serve.
Our pathologists have extensive experience in processing and interpreting specimens taken from the gynecologic brush devices on the market today. Gynecor’s TruTest® utilizes the Tao Brush™, a more gentle procedure for endometrial biopsy. Both the SpiraBrush® and SoftBiopsy® devices used for cervical biopsy are minimally invasive devices that provide ample tissue specimen for evaluation. Each of these devices delivers comprehensive results with less pain for the patient.
Gynecor also processes gynecologic specimens collected by all methods, providing accurate and reliable diagnosis for each and every case.
Gynecor now also offers CerVysion™, a new molecular risk assessment test that aids in monitoring possible progression to cervical cancer. The increased sensitivity of CerVysion allows for earlier detection and may mark the potential for progression of precursor lesions providing options for timely treatment.
Jing Liu, M.D.
Molecular Pathology Director
Prior to joining Bostwick Laboratories, Dr. Liu served five years as a staff pathologist ... Read More
Disclaimer: This tool is a guide based on the General Equivalency Mapping (GEM) files published by CMS, and is not intended to be used as a standalone ICD-10 conversion, ICD-10 mapping, or ICD-9 to ICD-10 crosswalk tool. Keep in mind that while many codes in ICD-9-CM map directly to codes in ICD-10, there are cases where a clinical analysis may be required to determine which code or codes should be selected for your mapping. Always review mapping results before applying them.